Failure to procure advanced tech, weapons threatens IDF’s combat readiness – analysis

Failure to procure advanced tech, weapons threatens IDF’s combat readiness – analysis

[ad_1] IDF’s procurement failures threaten future combat readiness | The Jerusalem PostJerusalem Post/Defense & Tech The IDF and Defense Ministry are working to mitigate the failure to secure advanced weapons and tech, that raised concerns about its readiness for future conflicts, reducing soldiers’ effectiveness. IDF soldiers operating in the Gaza Strip, August 1, 2025.(photo credit:…

Read More
Augmenting Brain Power: Real-World Data, Advanced Analytics, and the Future of Clinical Trials

Augmenting Brain Power: Real-World Data, Advanced Analytics, and the Future of Clinical Trials

[ad_1] In today’s ultra-competitive global marketplace, life sciences companies are continually seeking ways to improve their research effectiveness and efficiency. Increasingly, real-world data (RWD) is becoming a source and focus of these efforts. With advanced cloud technologies enabling the collection, storage, and analysis of petabytes of information, the vast realm of RWD is now open…

Read More
SPYI Is Proving To Be An Advanced Income Generating Solution, Yielding 11.62%

Why Super Micro Computer, Advanced Micro Devices, and Other Artificial Intelligence (AI) Stocks Tumbled on Tuesday

[ad_1] After the market close on Monday, Nvidia (NASDAQ: NVDA) kicked off its annual GPU Technology Conference (GTC), which some have dubbed the “Woodstock of Artificial Intelligence (AI).” Thousands of tech glitterati showed up in person to watch CEO Jensen Huang’s keynote address, while millions more tuned in online. During the two-hour presentation, Huang expounded…

Read More
FDA accepts BeiGene’s application for advanced cancer treatment

FDA accepts BeiGene’s application for advanced cancer treatment

[ad_1] © Reuters. BASEL, Switzerland – The U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) from BeiGene (NASDAQ:), Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE (LON:): 688235) for TEVIMBRA® (tislelizumab) in combination with chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma treatment. The agency has set a Prescription Drug User…

Read More